AR122736A1 - Anticuerpos que reconocen sortilina - Google Patents

Anticuerpos que reconocen sortilina

Info

Publication number
AR122736A1
AR122736A1 ARP210101748A ARP210101748A AR122736A1 AR 122736 A1 AR122736 A1 AR 122736A1 AR P210101748 A ARP210101748 A AR P210101748A AR P210101748 A ARP210101748 A AR P210101748A AR 122736 A1 AR122736 A1 AR 122736A1
Authority
AR
Argentina
Prior art keywords
sortilin
antibodies recognizing
antibodies
delay
changes
Prior art date
Application number
ARP210101748A
Other languages
English (en)
Inventor
Andriani Ioannou
Tarlochan S Nijjar
Original Assignee
Prothena Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothena Biosciences Ltd filed Critical Prothena Biosciences Ltd
Publication of AR122736A1 publication Critical patent/AR122736A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/71—Decreased effector function due to an Fc-modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Abstract

La invención provee anticuerpos que se unen específicamente a sortilina. Los anticuerpos inhiben o demoran patologías asociadas con cambios en los niveles de progranulina y deterioro sintomático asociado.
ARP210101748A 2020-06-24 2021-06-24 Anticuerpos que reconocen sortilina AR122736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063043481P 2020-06-24 2020-06-24

Publications (1)

Publication Number Publication Date
AR122736A1 true AR122736A1 (es) 2022-10-05

Family

ID=79281994

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101748A AR122736A1 (es) 2020-06-24 2021-06-24 Anticuerpos que reconocen sortilina

Country Status (12)

Country Link
US (3) US20230235048A1 (es)
EP (1) EP4171743A1 (es)
JP (1) JP2023533458A (es)
KR (1) KR20230026489A (es)
CN (1) CN116249717A (es)
AR (1) AR122736A1 (es)
AU (1) AU2021297540A1 (es)
BR (1) BR112022026508A2 (es)
CA (1) CA3183994A1 (es)
IL (1) IL299329A (es)
TW (1) TW202216773A (es)
WO (1) WO2021263279A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230348588A1 (en) * 2021-12-23 2023-11-02 Prothena Biosciences Limited Antibodies recognizing sortilin
WO2023247754A1 (en) 2022-06-23 2023-12-28 Draupnir Bio Aps Bifunctional molecules that selectively induce degradation of extracellular targets in lysosomes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007217765A1 (en) * 2006-02-21 2007-08-30 Nanogen, Inc. Methods and compositions for analyte detection
LT2954779T (lt) * 2009-12-10 2019-05-27 Regeneron Pharmaceuticals, Inc. Pelės, gaminančios sunkiosios grandinės antikūnus
CA2791658C (en) * 2010-03-04 2019-10-01 Macrogenics, Inc. Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
EP2844675B1 (en) * 2012-05-02 2019-01-02 Symphogen A/S Humanized pan-her antibody compositions
ES2899227T3 (es) * 2015-04-07 2022-03-10 Alector Llc Anticuerpos anti sortilina y métodos de uso de los mismos

Also Published As

Publication number Publication date
US20230235048A1 (en) 2023-07-27
IL299329A (en) 2023-02-01
WO2021263279A1 (en) 2021-12-30
KR20230026489A (ko) 2023-02-24
EP4171743A1 (en) 2023-05-03
CN116249717A (zh) 2023-06-09
BR112022026508A2 (pt) 2023-03-07
AU2021297540A1 (en) 2023-02-02
TW202216773A (zh) 2022-05-01
US20240117039A1 (en) 2024-04-11
CA3183994A1 (en) 2021-12-30
JP2023533458A (ja) 2023-08-03
US20240117040A1 (en) 2024-04-11

Similar Documents

Publication Publication Date Title
CO2021011140A2 (es) Anticuerpos que reconocen tau
UY38601A (es) Anticuerpos que reconocen tau
CO2019013265A2 (es) Anticuerpos que reconocen tau
CO2018012986A2 (es) Anticuerpos que reconocen tau
CO2018012987A2 (es) Anticuerpos que reconocen tau
CO2021007370A2 (es) Anticuerpos que reconocen tau
CU24446B1 (es) Un anticuerpo monoclonal humanizado que se une a tau
AR122736A1 (es) Anticuerpos que reconocen sortilina
CU20210039A7 (es) Anticuerpos que reconocen tau
CR20170251A (es) Anticuerpos anti-c5 y métodos para su uso
UA45061S (uk) 1. футляр
CL2020002459A1 (es) Variantes de anticuerpo c-terminales
AR128076A1 (es) Anticuerpos que reconocen la sortilina
EA202191306A1 (ru) Антитела, распознающие тау
TR201903527U5 (tr) Follukta yeni̇li̇k
JP1752306S (ja) 書類ケース
JP1745428S (ja) 書類ケース
JP1745431S (ja) 書類ケース
JP1745429S (ja) 書類ケース
UA44765S (uk) 1. тверде паливо особливе
ES1288505Y (es) Pasta elaborada con gofio
JP1761938S (ja) ノート
JP1761936S (ja) ノート
UA42735S (uk) Гідроакумулятор паливний
UA45591S (uk) 1. бланк документа про вищу освіту тернопільського національного технічного університету імені івана пулюя